Alzheimer’s disease (AD) is a neurodegenerative disease that causes brain cell death. This progressive disease, which causes a distinct pattern of pathological changes in the brain, is most common ...

Alzheimer's disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally ...

Alzheimer's disease is a multifactorial neurodegenerative disorder, characterized by amyloid plaques, neurofibrillary tangles, and gliosis. Beyond genetic and age-related factors, diverse risk ...

(CNN) — Alzheimer’s disease is increasingly widespread, affecting more than 55 million people worldwide — a figure that’s expected to nearly triple by 2050. (CNN) — Alzheimer’s disease is increasingly ...

SEVEN NEWS. MORE THAN 53,000 NEW MEXICANS ARE EXPECTED TO HAVE ALZHEIMER’S DISEASE BY 2025. THE ALZHEIMER’S ASSOCIATION SAYS THAT’S AN INCREASE OF 2000 PEOPLE PER YEAR. WE ASKED KOAT, UNM HEALTH ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. Alzheimer’s disease has proved to be a ...

Dr. Solomon Carter Fuller, the first Black psychiatrist in the United States, contributed to early research on Alzheimer’s disease. - Boston University Photography Alzheimer’s disease is increasingly ...

(CNN) — Alzheimer’s disease is increasingly widespread, affecting more than 55 million people worldwide — a figure that’s expected to nearly triple by 2050. Despite the disease’s prevalence, few know ...